Skip to main content

Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Dual kinase inhibitor performs well in its first safety, efficacy study for atopic dermatitis

User login

Username

Password

Reset your password

Type	Lead	score